MA24626A1 - Compositions parenterales d'alatrofloxacine - Google Patents

Compositions parenterales d'alatrofloxacine

Info

Publication number
MA24626A1
MA24626A1 MA25198A MA25198A MA24626A1 MA 24626 A1 MA24626 A1 MA 24626A1 MA 25198 A MA25198 A MA 25198A MA 25198 A MA25198 A MA 25198A MA 24626 A1 MA24626 A1 MA 24626A1
Authority
MA
Morocco
Prior art keywords
alatrofloxacin
parenteral compositions
parenteral
compositions
Prior art date
Application number
MA25198A
Other languages
English (en)
Inventor
Robert Mark Guinn
John Francis Lambert
Stanley Walter Walinsky
Subramanian Sam Guhan
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA24626A1 publication Critical patent/MA24626A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MA25198A 1997-08-01 1998-07-31 Compositions parenterales d'alatrofloxacine MA24626A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01

Publications (1)

Publication Number Publication Date
MA24626A1 true MA24626A1 (fr) 1999-04-01

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25198A MA24626A1 (fr) 1997-08-01 1998-07-31 Compositions parenterales d'alatrofloxacine

Country Status (40)

Country Link
US (1) US6194429B1 (fr)
EP (1) EP1000086B1 (fr)
JP (1) JP3463928B2 (fr)
KR (1) KR20010022495A (fr)
CN (1) CN1265671A (fr)
AP (1) AP1031A (fr)
AR (1) AR015417A1 (fr)
AT (1) ATE259827T1 (fr)
AU (1) AU734863B2 (fr)
BG (1) BG104105A (fr)
BR (1) BR9811580A (fr)
CA (1) CA2296466C (fr)
CO (1) CO4970688A1 (fr)
DE (1) DE69821767T2 (fr)
DK (1) DK1000086T3 (fr)
DZ (1) DZ2576A1 (fr)
EA (1) EA002120B1 (fr)
ES (1) ES2214716T3 (fr)
GT (1) GT199800112A (fr)
HN (1) HN1998000106A (fr)
HR (1) HRP980417B1 (fr)
HU (1) HUP0004793A3 (fr)
ID (1) ID24374A (fr)
IL (1) IL134156A0 (fr)
IS (1) IS5339A (fr)
MA (1) MA24626A1 (fr)
NO (1) NO20000485L (fr)
NZ (1) NZ502249A (fr)
OA (1) OA11281A (fr)
PA (1) PA8456701A1 (fr)
PE (1) PE103799A1 (fr)
PL (1) PL338477A1 (fr)
PT (1) PT1000086E (fr)
SK (1) SK1012000A3 (fr)
TN (1) TNSN98146A1 (fr)
TW (1) TW538043B (fr)
UY (1) UY25113A1 (fr)
WO (1) WO1999006430A1 (fr)
YU (1) YU2500A (fr)
ZA (1) ZA986874B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4803935B2 (ja) * 1999-10-08 2011-10-26 アフィニアム・ファーマシューティカルズ・インコーポレイテッド Fabi阻害剤
EP1121933A1 (fr) * 2000-02-02 2001-08-08 Pfizer Products Inc. Compositions prémélangées injectables d'alatrofloxacin
EP1560584B1 (fr) * 2001-04-06 2009-01-14 Affinium Pharmaceuticals, Inc. Inhibiteurs de fab i
DK1575951T3 (da) * 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
JP4880448B2 (ja) 2003-03-17 2012-02-22 アフィナム ファーマシューティカルズ,インコーポレーテッド 複数の抗生物質を含む組成物、及びそれを用いる方法
CA2467321A1 (fr) * 2004-05-14 2005-11-14 Paul J. Santerre Agents de couplage polymeres et polymeres ayant une activite pharmaceutique produits a partir de ceux-ci
WO2007053131A2 (fr) 2004-06-04 2007-05-10 Affinium Pharmaceuticals, Inc. Agents thérapeutiques et méthodes pour les fabriquer et les utiliser
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
CA2658506C (fr) 2006-07-20 2016-01-26 Affinium Pharmaceuticals, Inc. Derives d'acrylamide en tant qu'inhibiteurs de fab 1
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
KR101720885B1 (ko) 2012-06-19 2017-03-28 데비오팜 인터네셔날 에스 에이 (e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
WO2015164859A1 (fr) * 2014-04-25 2015-10-29 Naurex, Inc. Compositions stables de peptides neuroactifs
LT3419628T (lt) 2016-02-26 2021-01-25 Debiopharm International Sa Medikamentas diabetinėms pėdų infekcijoms gydyti
WO2019148294A1 (fr) 2018-02-02 2019-08-08 Interface Biologics, Inc. Compositions de promédicaments de dexaméthasone dimères et leurs utilisations
WO2021220061A2 (fr) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Compositions hétérodimères et méthodes pour le traitement de troubles oculaires

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
WO1995019361A1 (fr) 1994-01-18 1995-07-20 Pfizer Inc. Procede et intermediaires destines a la preparation de sels d'acide naphtyridonecarboxylique
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
ES2117426T3 (es) 1995-06-06 1998-08-01 Pfizer Forma cristalina de la sal anhidra compuesta de los acidos 7-((1a,5a,6a)-6-amino-3-azabiciclo(3.1.0.)hex-3-il)-6-fluoro-1-(2,4-difluorofenil)-1,4-dihidro-4-oxo-1,8-naftiridina-3-carboxilico y metanosulfonico.
ES2178701T3 (es) * 1995-06-15 2003-01-01 Pfizer Procedimiento para preparar derivados del acido azabiciclo naftriridina carboxilico que comprenden un dipeptido.
WO1997007800A1 (fr) 1995-08-29 1997-03-06 Pfizer Inc. Formes zwitterioniques de trovafloxacine
TR199800340T1 (xx) 1995-08-29 1998-06-22 Pfizer Inc. �n-ila� 6-N-(L-ALA-L-ALA)-trovafloksasin polimorflar�.
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
JP2001512133A (ja) 2001-08-21
ID24374A (id) 2000-07-13
HN1998000106A (es) 1999-01-08
TW538043B (en) 2003-06-21
CA2296466A1 (fr) 1999-02-11
IL134156A0 (en) 2001-04-30
AU734863B2 (en) 2001-06-21
OA11281A (en) 2002-11-19
CO4970688A1 (es) 2000-11-07
NO20000485D0 (no) 2000-01-31
EA002120B1 (ru) 2001-12-24
EP1000086B1 (fr) 2004-02-18
PA8456701A1 (es) 2000-05-24
US6194429B1 (en) 2001-02-27
PT1000086E (pt) 2004-05-31
BR9811580A (pt) 2000-08-22
DE69821767T2 (de) 2005-01-13
KR20010022495A (ko) 2001-03-15
ZA986874B (en) 2000-01-31
HRP980417A2 (en) 1999-08-31
YU2500A (sh) 2002-09-19
SK1012000A3 (en) 2000-09-12
TNSN98146A1 (fr) 2005-03-15
IS5339A (is) 2000-01-14
PL338477A1 (en) 2000-11-06
BG104105A (bg) 2000-08-31
NZ502249A (en) 2001-11-30
PE103799A1 (es) 1999-10-25
EP1000086A1 (fr) 2000-05-17
AR015417A1 (es) 2001-05-02
DZ2576A1 (fr) 2003-02-22
AP9801310A0 (en) 1998-09-30
JP3463928B2 (ja) 2003-11-05
HUP0004793A3 (en) 2001-10-29
GT199800112A (es) 2000-01-15
HRP980417B1 (en) 2002-10-31
DE69821767D1 (de) 2004-03-25
AP1031A (en) 2001-12-21
AU8236898A (en) 1999-02-22
WO1999006430A1 (fr) 1999-02-11
ATE259827T1 (de) 2004-03-15
HUP0004793A2 (hu) 2001-04-28
UY25113A1 (es) 2000-12-29
CN1265671A (zh) 2000-09-06
DK1000086T3 (da) 2004-05-17
EA200000086A1 (ru) 2000-08-28
NO20000485L (no) 2000-03-27
CA2296466C (fr) 2003-04-15
ES2214716T3 (es) 2004-09-16

Similar Documents

Publication Publication Date Title
ITMI931611A0 (it) Composizione di gasolio
DE69815099D1 (de) Kosmetische zusammensetzungen
DE69616804D1 (de) Wasserdispergierbare copolyester-ether zusammensetzungen
MA24626A1 (fr) Compositions parenterales d'alatrofloxacine
ITMI941407A0 (it) Composizioni cementizie mdf con migliorata tenacita'
BR9607427A (pt) Inibiçao de angiogêne usando interleucina 12
TR199701051A3 (tr) 2' -Fluoro-5-metil- -l-arabino-furanosilüridin hazirlanma prosesi
ID16838A (id) Komposisi dekafluoropentana
IT244003Y1 (it) Tenuta d'albero
ID17419A (id) Komposisi dekafluoropentana
FR2710673B1 (fr) Composition d'enduit de parement.
FR2761461B1 (fr) Etancheite d'une table de cuisson
FR2735986B3 (fr) Prolongateur d'haltere
UA1629S (uk) Набір фестонів "веснянка-5"
UA2139S (uk) Обкладинка телефонного довідника "жовті сторінки"
ITMI951551A0 (it) Composizioni orosolubili di n-acetilcisteina
UA1914S (uk) Крекер "фірмовий"
UA2343S (uk) Комплект етикеток "мелітопольська ювілейна "віват"
UA25662A (uk) Аперитив "дебют"
SE9703724D0 (sv) Flexskiva "Flexigrund"
IT243309Y1 (it) Contenitore - espositore per pluralita' di oggetti
UA1904S (uk) Набір етикеток "недригайлівська"
UA1496S (uk) Набір етикеток "зубровка"
UA1499S (uk) Набір етикеток "гусарська"
UA1498S (uk) Набір етикеток "сумська горобинова"